Promoted Companies

 Tonny are you ready? Put ELTP on your radar now! Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company developing a pipeline of proprietary pharmacological abuse-deterrent opioid products and niche generic products. Elite specializes in oral sustained and controlled release drug products with high barriers to entry. Elite owns generic and OTC products licensed to TAGI Pharma, ...read more

Promoter:

Stockpalooza.com

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
ELTP	$300,000	1,921,464
Max Profit: 6.87 %	Gain at close: 5.60 %

    http://www.elitepharma.com/   ELITE PHARMACEUTICALS INITIATES PIVOTAL BIOEQUIVALENCE STUDY FOR SECOND OPIOID ABUSE DETERRENT PRODUCT Northvale, New Jersey, Tuesday, January 14, 2014: Elite Pharmaceuticals, Inc. ("Elite" or the “Company") ("Elite”) (OTCBB: ELTP) announced today the first dosing of a pivotal bioequivalence study in healthy volunteers for an undisclosed opioid abuse deterrent product utilizing ...read more

Promoter:

Pennybuster.com

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
ELTP	No compensation	UNKNOWN
Max Profit: 9.15 %	Gain at close: 8.24 %

Elite Pharmaceuticals, Inc. (ELTP) Elite Pharmaceuticals, Inc. (ELTP) develops oral sustained and controlled release products. The company's strategy includes assisting partner companies in the life cycle management of products to improve off-patent drug products and developing generic versions of controlled release drug products with high barriers to entry.   Overview of pipeline   ELTP has seven commercial ...read more

Promoter:

PST Alerts

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
ELTP	No compensation	UNKNOWN
Max Profit: 0.32 %	Gain at close: -2.30 %

Elite Pharmaceuticals, Inc. (ELTP) Elite Pharmaceuticals, Inc. (ELTP) develops oral sustained and controlled release products. The company's strategy includes assisting partner companies in the life cycle management of products to improve off-patent drug products and developing generic versions of controlled release drug products with high barriers to entry.   Overview of pipeline   ELTP has seven commercial ...read more

Promoter:

Buzz Stocks

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
ELTP	No compensation	UNKNOWN
Max Profit: 0.32 %	Gain at close: -2.30 %

  PSP Free Members, I've found an incredible new pharma-play for members that I believe could be poised for a breakout in the days ahead.  With a bullish technical setup, not to mention the company recently reporting $4.6M in Revenue for Fiscal 2014; our new pick looks to be setting up for a big move in the days ahead.   The company has now reported 3 straight years of revenue growth and is beginning to emerge as one of the leaders ...read more

Promoter:

Penny Stock Prophet

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
ELTP	No compensation	UNKNOWN
Max Profit: 0.32 %	Gain at close: -2.30 %

    PICK FOR: Monday, July 28, 2014   OTC: ELTP       Elite Pharmaceuticals, Inc. (ELTP)       Attention Traders!   We’ve discovered an incredible new “pharma” pick for members that we believe could be setting up for a potential breakout in the sessions ahead.   With a bullish technical setup, not to mention the company recently reporting ...read more

Promoter:

Penny Pick Finders

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
ELTP	No compensation	UNKNOWN
Max Profit: 0.32 %	Gain at close: -2.30 %

Our New Breakout Alert is: ELTP   MC Members, We have an amazing new alert opportunity for all subscribers.  This company is having an amazing turnaround year with $4.6 million revenues for Fiscal 2014. Our new pick looks well positioned to potentially see even greater growth moving forward with an impressive pipeline that continues to expand. In fact, This Company has emerged as one of the leaders ...read more

Promoter:

The MarketCaliber Team

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
ELTP	No compensation	UNKNOWN
Max Profit: 0.32 %	Gain at close: -2.30 %

My Promoted Stock For Monday: ELTP Secret Stock Members,       We have an amazing new alert opportunity for all subscribers.  This company is having an amazing turnaround year with $4.6 million revenues for Fiscal 2014. My new pick looks well positioned to potentially see even greater growth moving forward with an impressive pipeline that continues to expand. In fact, This ...read more

Promoter:

SecretStockPromoter

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
ELTP	No compensation	UNKNOWN
Max Profit: 0.32 %	Gain at close: -2.30 %

  Monday's new pick is: ELTP   SSP Subscribers, We have an amazing new alert opportunity for all subscribers.  This company is having an amazing turnaround year with $4.6 million revenues for Fiscal 2014. My new pick looks well positioned to potentially see even greater growth moving forward with an impressive pipeline that continues to expand. In fact, This Company has emerged as one of the leaders in the development ...read more

Promoter:

SecretStockPromo

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
ELTP	No compensation	UNKNOWN
Max Profit: 0.32 %	Gain at close: -2.30 %

          ELTP Is On Our Watchlist       Good Morning Traders I hope that you've watching our last alert... If you haven't, there still is time to do your DD and get up to date before the big news day on July first. If you haven't done so already, start your research on Elite Pharmaceuticals, Inc. (ELTP) immediately.       Priced ...read more

Promoter:

Impressive Penny Stocks

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
ELTP	No compensation	UNKNOWN
Max Profit: 2.11 %	Gain at close: -5.43 %